July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Biomarkers of diabetic retinopathy based on dynamic fluorescein angiography in control and diabetic patients
Author Affiliations & Notes
  • William F Mieler
    Illinois Eye & Ear Infirmary, Winnetka, Illinois, United States
  • Patrick Mogianesi
    Dept of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois, United States
  • Jason Wu
    Dept of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois, United States
  • Carol Yim-lui Cheung
    Dept of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Danny Ng
    Dept of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Zihan Sun
    Dept of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Yolanda W.Y. Yip
    Dept of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, Hong Kong, Hong Kong
  • Kenneth M. Tichauer
    Dept of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois, United States
  • Jennifer J Kang-Mieler
    Dept of Biomedical Engineering, Illinois Institute of Technology, Chicago, Illinois, United States
  • Footnotes
    Commercial Relationships   William Mieler, None; Patrick Mogianesi, None; Jason Wu, None; Carol Cheung, None; Danny Ng, None; Zihan Sun, None; Yolanda Yip, None; Kenneth Tichauer, None; Jennifer Kang-Mieler, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1926. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      William F Mieler, Patrick Mogianesi, Jason Wu, Carol Yim-lui Cheung, Danny Ng, Zihan Sun, Yolanda W.Y. Yip, Kenneth M. Tichauer, Jennifer J Kang-Mieler; Biomarkers of diabetic retinopathy based on dynamic fluorescein angiography in control and diabetic patients
      . Invest. Ophthalmol. Vis. Sci. 2018;59(9):1926.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The purpose was to demonstrate that the retinal vascular permeability and volumetric blood flow mapping from dynamic fluorescein angiography and kinetic tracer modeling can detect vascular changes in diabetic patients.

Methods : A routine fluorescein angiogram (FA) was performed in two normal control subjects and three diabetic patients. A small bolus of fluorescein dye (0.5 ml of 10%) was injected to obtain videoangiograms (30°, 90 sec movie) using Heidelberg Spectralis. The images were obtained immediately after the injection to capture the initial filling of the blood vessels. The fluorescein images were loaded into MATLAB. Eye movement was corrected via a motion correction algorithm. Either plug-flow or AATH tracer kinetic model was applied to obtain retinal vascular permeability and blood flow maps from the control and diabetic patients.

Results : Control subjects had no ocular abnormality. Based on the kinetic model analysis, the control subjects had average volumetric blood flow of 11.87 ± 3.51 ml/min/100g. The average vascular permeability (extraction fraction) for the control subjects was 0.0036 ± 0.0011. The diabetic patients had no DR to mild non-proliferative DR. The patients also had signs of diabetic macular edema. For the diabetic patients, the average volumetric blood flow was 8.47 ± 1.15 ml/min/100g. The average vascular permeability from the diabetic patients increased to 0.082 ±. 0.057. There were significant differences in vascular permeability.

Conclusions : The current data demonstrated that dynamic fluorescein enhanced fluorescent imaging and tracer kinetic model can detect changes of volumetric blood flow and vascular permeability in diabetic patients. Specifically, an increase in the vascular permeability, in absence of proliferation, may be a sensitive parameter to detect vascular abnormality. This study demonstrated that the vascular permeability and blood flow may be powerful biomarkers for early detection of DR.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×